Stocks and Investing
Stocks and Investing
Mon, July 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (BLND) at Hold with Decreased Target to $2.5 on, Jul 18th, 2022
Arvind Ramnani of Piper Sandler, Maintained "Blend Labs, Inc." (BLND) at Hold with Decreased Target from $3.5 to $2.5 on, Jul 18th, 2022.
Arvind has made no other calls on BLND in the last 4 months.
There are 7 other peers that have a rating on BLND. Out of the 7 peers that are also analyzing BLND, 6 agree with Arvind's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Josh Beck of "Keybanc" Downgraded from Buy to Hold and Held Target at $5 on, Thursday, July 7th, 2022
- Jason Weaver of "Compass Point" Initiated at Hold and Held Target at $4.2 on, Wednesday, May 25th, 2022
- Michael Turrin of "Wells Fargo" Maintained at Hold with Decreased Target to $3 on, Friday, May 13th, 2022
- Bhavan Suri of "William Blair" Downgraded from Buy to Hold on, Monday, April 4th, 2022
- Terry Tillman of "Truist Securities" Maintained at Hold with Decreased Target to $5.5 on, Friday, April 1st, 2022
- Joseph Vafi of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $5 on, Friday, April 1st, 2022
This is the rating of the analyst that currently disagrees with Arvind
- Michael Ng of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $7 on, Tuesday, April 19th, 2022
Contributing Sources